Analysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Nkarta (NKTX)
TipRanksApr 10 19:00
Needham: Reiterates Evolus (EOLS.US) rating and adjusted from buy to buy rating, target price is $22.00.
Zhitong FinanceApr 10 18:50
Evolus Analyst Ratings
BenzingaApr 10 18:45
Needham Reiterates Buy on Evolus, Maintains $22 Price Target
BenzingaApr 10 18:47
Analysts Offer Insights on Healthcare Companies: Sangamo Biosciences (SGMO) and Evolus (EOLS)
TipRanksMar 14 17:00
Evolus (EOLS) Receives a Buy From Barclays
TipRanksMar 11 14:35
Evolus Poised for Growth: Buy Rating Affirmed With $25 Price Target Amid Profitability Forecast and Competitive Market Positioning
TipRanksMar 11 12:45
Evolus Analyst Ratings
BenzingaMar 8 19:53
HC Wainwright & Co. Reiterates Buy on Evolus, Maintains $27 Price Target
BenzingaMar 2 03:15
Evolus Analyst Ratings
BenzingaMar 2 03:14
Analysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Akero Therapeutics (AKRO)
TipRanksMar 2 01:40
Analysts Offer Insights on Healthcare Companies: Cigna (CI), Evolus (EOLS) and Hologic (HOLX)
TipRanksFeb 5 17:20
Evolus Analyst Ratings
BenzingaJan 29 18:22
Analysts' Top Healthcare Picks: Instil Bio (TIL), Evolus (EOLS)
TipRanksJan 23 04:30
Analysts Offer Insights on Healthcare Companies: Lexaria Bioscience (LEXX), Evolus (EOLS) and Inspire Medical Systems (INSP)
TipRanksJan 23 04:01
Evolus Analyst Ratings
BenzingaJan 17 19:20
Evolus Stock (NASDAQ:EOLS) Spikes; Analysts See Significant Upside
TipRanksJan 17 15:39
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC) and Evolus (EOLS)
TipRanksDec 25, 2023 14:00
Analysts Are Bullish on These Healthcare Stocks: Enlivex (ENLV), Evolus (EOLS)
TipRanksDec 21, 2023 19:30
Evolus Analyst Ratings
BenzingaDec 21, 2023 01:39
No Data
No Data